SPDR S&P Pharmaceuticals ETF logo

SPDR S&P Pharmaceuticals ETF (XPH)

Market Closed
27 Jul, 20:00
ARCA ARCA
$
68. 54
+0.59
+0.8683%
$
277.3M Market Cap
0.62% Div Yield
187,274 Volume
$ 67.95
Previous Close
Add Transaction
Day Range
68.31 69.6
Year Range
40.8 70.15
Want to track XPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

SPDR S&P Pharmaceuticals ETF Investors

Name Quantity Cost Value Profit ($) Gain (%)
TJD
Thomas John Drogan PR Inc.IPAL SECURITIES Inc.
6,151 $300,727.71 $416,668.74 $115,941.03 38.55%
Kyle P. Smith
Kyle P. Smith NewEdge Wealth LLC
4,033 $173,393.2 $273,235.75 $99,842.55 57.58%
Kurt Van Dyken
Kurt Van Dyken Lifeworks Advisors LLC
4,503 $243,567.27 $304,290.22 $60,722.95 24.93%
CAL
CoreCap Advisors LLC CoreCap Advisors LLC
41 $1,768.33 $2,749.46 $981.13 55.48%
CWM
Compass Wealth Management LLC Compass Wealth Management LLC
24,153 $1.34M $1.64M $302,935.92 22.6%
Christopher C. Powers
Christopher C. Powers Farther Finance Advisors, LLC
3,970 $217,277.55 $266,228.19 $48,950.64 22.53%
Envestnet Portfolio Solutions Inc.
Envestnet Portfolio Solutions Inc. Envestnet Portfolio Solutions, Inc.
171,479 $7.23M $11.5M $4.27M 59.16%
Julie Beswick
Julie Beswick Advantage Trust Co
3,250 $215,378 $221,276.25 $5,898.25 2.74%
Cynthia Schlanger
Cynthia Schlanger Ashton Thomas Private Wealth, LLC
351 $18,986 $23,901.34 $4,915.34 25.89%
MA
Marie-Andree Alain Federation des caisses Desjardins du Quebec
400 $14,235.93 $26,824 $12,588.07 88.42%
SummitTX Capital LP
SummitTX Capital LP SummitTX Capital LP
15,577 $842,560 $1.06M $221,816.41 26.33%
Matthew Francis Dean
Matthew Francis Dean Evelyn Partners Investment Management (Europe) Ltd.
4,250 $203,744.54 $290,933.75 $87,189.21 42.79%